000070654 001__ 70654
000070654 005__ 20200221144240.0
000070654 0247_ $$2doi$$a10.1177/2050640615595916
000070654 0248_ $$2sideral$$a106028
000070654 037__ $$aART-2016-106028
000070654 041__ $$aeng
000070654 100__ $$aPique, N.
000070654 245__ $$aPrevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)
000070654 260__ $$c2016
000070654 5060_ $$aAccess copy available to the general public$$fUnrestricted
000070654 5203_ $$aBackground The current prevalence of esophagitis in southern Europe is unknown. In addition, the risk factors for reflux esophagitis are not fully understood. Objective The objective of this article is to assess the prevalence and risk factors for esophagitis in Spain. Methods A prospective, observational, cross-sectional, multicenter study (PRESS study) was conducted among 31 gastrointestinal endoscopy units throughout Spain. A total of 1361 patients undergoing upper gastrointestinal endoscopy were enrolled. Sociodemographic, clinical and treatment data were recorded. Results A total of 95% of patients were Caucasian and 52% were male (mean age: 5317 years). The most frequent symptoms prompting endoscopy were heartburn (40%), regurgitation (26%) and dysphagia (15%). Fifty-four percent of patients undergoing endoscopy were receiving proton pump inhibitor (PPI) treatment. Esophagitis (mainly mild-moderate) was present in 154 (12.4%) patients. The severe form was recorded in only 11 (0.8%) patients. Multivariate analysis results indicated that the likelihood of esophagitis was higher in men (OR=1.91, 95% CI=1.31-2.78), in patients with high GERD-Q scores (OR=1.256, 95% CI=1.176-1.343), weight increase (OR=1.014, 95% CI=1.003-1.025) and high alcohol consumption (OR=2.49, 95% CI=1.16-5.36). Conclusion Severe esophagitis is a rare finding in the Spanish population. Male gender, high GERD-Q score, weight increase and high alcohol consumption are main risk factors for its appearance.
000070654 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
000070654 590__ $$a3.673$$b2016
000070654 591__ $$aGASTROENTEROLOGY & HEPATOLOGY$$b21 / 79 = 0.266$$c2016$$dQ2$$eT1
000070654 592__ $$a1.137$$b2016
000070654 593__ $$aOncology$$c2016$$dQ2
000070654 593__ $$aGastroenterology$$c2016$$dQ2
000070654 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000070654 700__ $$aPonce, M.
000070654 700__ $$aGarrigues, V.
000070654 700__ $$aRodrigo, L.
000070654 700__ $$aCalvo, F.
000070654 700__ $$ade Argila, C.M.
000070654 700__ $$aBorda, F.
000070654 700__ $$aNaranjo, A.
000070654 700__ $$0(orcid)0000-0001-6522-6682$$aAlcedo, J.
000070654 700__ $$aSoria, M.J.
000070654 700__ $$aRey, E.
000070654 700__ $$aBujanda, L.
000070654 700__ $$aGisbert, J.P.
000070654 700__ $$aSuarez, D.
000070654 700__ $$aCalvet, X.
000070654 700__ $$aPonce, J.
000070654 773__ $$g4, 2 (2016), 229-235$$pUnited European Gastroenterol. j.$$tUnited European Gastroenterology Journal$$x2050-6406
000070654 8564_ $$s230615$$uhttps://zaguan.unizar.es/record/70654/files/texto_completo.pdf$$yVersión publicada
000070654 8564_ $$s98128$$uhttps://zaguan.unizar.es/record/70654/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000070654 909CO $$ooai:zaguan.unizar.es:70654$$particulos$$pdriver
000070654 951__ $$a2020-02-21-13:21:39
000070654 980__ $$aARTICLE